سعر ليبوفوندين MCT/LCT 10% مستحلب للتسريب الوريدي 2022

Lipofundin MCT/LCT 10% emulsion for i.v. infusion (B. Braun Melsungen AG, Germany; distributed by Sunny Medical in Egypt): lipid emulsion of soya-bean oil and medium-chain triglycerides for parenteral nutrition.

• Energy supply including a readily utilisable lipid component (MCT) and supply of essential fatty acids as part of total parenteral nutrition when oral or enteral nutrition is impossible, insufficient or contraindicated.Population: Adults and paediatric patients requiring parenteral nutritionCIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• Under correct use most reactions are very rare (hypercoagulability, allergic reactions, hyperlipidaemia, hyperglycaemia, metabolic acidosis, ketoacidosis, headache, drowsiness, hypertension or hypotension, flush, dyspnoea, cyanosis, nausea, vomiting, loss of appetite, erythema, sweating, back/bone/chest/lumbar pain); frequency not known: leucopenia, thrombocytopenia, cholestasis.International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• Hypersensitivity to egg or soya-bean protein, soya-bean or peanut products or any ingredient; severe hyperlipidaemia; severe coagulopathy; severe hepatic insufficiency; intrahepatic cholestasis; severe renal insufficiency without renal replacement therapy; acute thromboembolic events; fat embolism; aggravating haemorrhagic diatheses; metabolic acidosis; plus general contraindications to parenteral nutrition (unstable circulation/shock, unstable metabolic conditions, acute phase of MI or stroke, uncorrected fluid/electrolyte disorders, decompensated cardiac insufficiency, acute pulmonary oedema).International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

• Safety not established and data limited, so use in pregnant women should be avoided; parenteral nutrition may be necessary in pregnancy, and the product should only be given after careful benefit-risk consideration.International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
• Components and metabolites are excreted in breast milk, with no effects expected at therapeutic doses; in general, breastfeeding is not recommended in women receiving parenteral nutrition.International label, same formulation · CIMA - Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

English text not available for this section.